nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Vinblastine—testicular cancer	0.21	0.328	CbGbCtD
Famotidine—SLC22A2—Cisplatin—testicular cancer	0.193	0.301	CbGbCtD
Famotidine—CYP2C19—Ifosfamide—testicular cancer	0.131	0.204	CbGbCtD
Famotidine—SLC22A8—Methotrexate—testicular cancer	0.107	0.167	CbGbCtD
Famotidine—Pancytopenia—Methotrexate—testicular cancer	0.000519	0.00145	CcSEcCtD
Famotidine—Anaphylactic shock—Etoposide—testicular cancer	0.000518	0.00145	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000516	0.00144	CcSEcCtD
Famotidine—Infection—Etoposide—testicular cancer	0.000515	0.00144	CcSEcCtD
Famotidine—Asthenia—Dactinomycin—testicular cancer	0.000514	0.00143	CcSEcCtD
Famotidine—Influenza—Epirubicin—testicular cancer	0.000511	0.00143	CcSEcCtD
Famotidine—Neutropenia—Methotrexate—testicular cancer	0.000511	0.00143	CcSEcCtD
Famotidine—Dysuria—Methotrexate—testicular cancer	0.000511	0.00143	CcSEcCtD
Famotidine—Paraesthesia—Cisplatin—testicular cancer	0.000508	0.00142	CcSEcCtD
Famotidine—Thrombocytopenia—Etoposide—testicular cancer	0.000508	0.00142	CcSEcCtD
Famotidine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000508	0.00142	CcSEcCtD
Famotidine—Erectile dysfunction—Methotrexate—testicular cancer	0.000503	0.0014	CcSEcCtD
Famotidine—Dry skin—Doxorubicin—testicular cancer	0.000501	0.0014	CcSEcCtD
Famotidine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000498	0.00139	CcSEcCtD
Famotidine—Anorexia—Etoposide—testicular cancer	0.000494	0.00138	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000493	0.00137	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000493	0.00137	CcSEcCtD
Famotidine—Decreased appetite—Cisplatin—testicular cancer	0.000492	0.00137	CcSEcCtD
Famotidine—Bronchitis—Epirubicin—testicular cancer	0.000491	0.00137	CcSEcCtD
Famotidine—Diarrhoea—Dactinomycin—testicular cancer	0.00049	0.00137	CcSEcCtD
Famotidine—Vomiting—Bleomycin—testicular cancer	0.000488	0.00136	CcSEcCtD
Famotidine—Depression—Methotrexate—testicular cancer	0.000485	0.00136	CcSEcCtD
Famotidine—Pancytopenia—Epirubicin—testicular cancer	0.000485	0.00135	CcSEcCtD
Famotidine—Rash—Bleomycin—testicular cancer	0.000484	0.00135	CcSEcCtD
Famotidine—Pain—Cisplatin—testicular cancer	0.000484	0.00135	CcSEcCtD
Famotidine—Dermatitis—Bleomycin—testicular cancer	0.000484	0.00135	CcSEcCtD
Famotidine—Hypersensitivity—Ifosfamide—testicular cancer	0.000484	0.00135	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000483	0.00135	CcSEcCtD
Famotidine—Dysuria—Epirubicin—testicular cancer	0.000478	0.00133	CcSEcCtD
Famotidine—Neutropenia—Epirubicin—testicular cancer	0.000478	0.00133	CcSEcCtD
Famotidine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000475	0.00133	CcSEcCtD
Famotidine—Influenza—Doxorubicin—testicular cancer	0.000473	0.00132	CcSEcCtD
Famotidine—Pollakiuria—Epirubicin—testicular cancer	0.000472	0.00132	CcSEcCtD
Famotidine—Asthenia—Ifosfamide—testicular cancer	0.000471	0.00131	CcSEcCtD
Famotidine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000466	0.0013	CcSEcCtD
Famotidine—Feeling abnormal—Cisplatin—testicular cancer	0.000466	0.0013	CcSEcCtD
Famotidine—Paraesthesia—Etoposide—testicular cancer	0.000466	0.0013	CcSEcCtD
Famotidine—Pruritus—Ifosfamide—testicular cancer	0.000464	0.0013	CcSEcCtD
Famotidine—Haematuria—Methotrexate—testicular cancer	0.000464	0.0013	CcSEcCtD
Famotidine—Somnolence—Etoposide—testicular cancer	0.000461	0.00129	CcSEcCtD
Famotidine—Nausea—Bleomycin—testicular cancer	0.000456	0.00127	CcSEcCtD
Famotidine—Vomiting—Dactinomycin—testicular cancer	0.000455	0.00127	CcSEcCtD
Famotidine—Bronchitis—Doxorubicin—testicular cancer	0.000455	0.00127	CcSEcCtD
Famotidine—Agranulocytosis—Methotrexate—testicular cancer	0.000454	0.00127	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000452	0.00126	CcSEcCtD
Famotidine—Rash—Dactinomycin—testicular cancer	0.000452	0.00126	CcSEcCtD
Famotidine—Decreased appetite—Etoposide—testicular cancer	0.000451	0.00126	CcSEcCtD
Famotidine—Diarrhoea—Ifosfamide—testicular cancer	0.000449	0.00125	CcSEcCtD
Famotidine—Pancytopenia—Doxorubicin—testicular cancer	0.000449	0.00125	CcSEcCtD
Famotidine—Body temperature increased—Cisplatin—testicular cancer	0.000447	0.00125	CcSEcCtD
Famotidine—Fatigue—Etoposide—testicular cancer	0.000447	0.00125	CcSEcCtD
Famotidine—Jaundice—Epirubicin—testicular cancer	0.000444	0.00124	CcSEcCtD
Famotidine—Pain—Etoposide—testicular cancer	0.000443	0.00124	CcSEcCtD
Famotidine—Constipation—Etoposide—testicular cancer	0.000443	0.00124	CcSEcCtD
Famotidine—Neutropenia—Doxorubicin—testicular cancer	0.000442	0.00123	CcSEcCtD
Famotidine—Dysuria—Doxorubicin—testicular cancer	0.000442	0.00123	CcSEcCtD
Famotidine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000439	0.00123	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—testicular cancer	0.000437	0.00122	CcSEcCtD
Famotidine—Pollakiuria—Doxorubicin—testicular cancer	0.000437	0.00122	CcSEcCtD
Famotidine—Haematuria—Epirubicin—testicular cancer	0.000434	0.00121	CcSEcCtD
Famotidine—Dizziness—Ifosfamide—testicular cancer	0.000434	0.00121	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—testicular cancer	0.000434	0.00121	CcSEcCtD
Famotidine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000432	0.0012	CcSEcCtD
Famotidine—Sinusitis—Epirubicin—testicular cancer	0.000427	0.00119	CcSEcCtD
Famotidine—Feeling abnormal—Etoposide—testicular cancer	0.000427	0.00119	CcSEcCtD
Famotidine—Nausea—Dactinomycin—testicular cancer	0.000425	0.00119	CcSEcCtD
Famotidine—Agranulocytosis—Epirubicin—testicular cancer	0.000425	0.00119	CcSEcCtD
Famotidine—Gastrointestinal pain—Etoposide—testicular cancer	0.000424	0.00118	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000418	0.00117	CcSEcCtD
Famotidine—Vomiting—Ifosfamide—testicular cancer	0.000417	0.00116	CcSEcCtD
Famotidine—Hypersensitivity—Cisplatin—testicular cancer	0.000417	0.00116	CcSEcCtD
Famotidine—Bradycardia—Epirubicin—testicular cancer	0.000416	0.00116	CcSEcCtD
Famotidine—Rash—Ifosfamide—testicular cancer	0.000414	0.00116	CcSEcCtD
Famotidine—Dermatitis—Ifosfamide—testicular cancer	0.000413	0.00115	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—testicular cancer	0.000413	0.00115	CcSEcCtD
Famotidine—Urticaria—Etoposide—testicular cancer	0.000412	0.00115	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—testicular cancer	0.000411	0.00115	CcSEcCtD
Famotidine—Abdominal pain—Etoposide—testicular cancer	0.00041	0.00114	CcSEcCtD
Famotidine—Body temperature increased—Etoposide—testicular cancer	0.00041	0.00114	CcSEcCtD
Famotidine—Hepatitis—Epirubicin—testicular cancer	0.000409	0.00114	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—testicular cancer	0.000408	0.00114	CcSEcCtD
Famotidine—Asthenia—Cisplatin—testicular cancer	0.000406	0.00113	CcSEcCtD
Famotidine—Pharyngitis—Epirubicin—testicular cancer	0.000406	0.00113	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—testicular cancer	0.000402	0.00112	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—testicular cancer	0.000396	0.0011	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—testicular cancer	0.000393	0.0011	CcSEcCtD
Famotidine—Nausea—Ifosfamide—testicular cancer	0.00039	0.00109	CcSEcCtD
Famotidine—Diarrhoea—Cisplatin—testicular cancer	0.000387	0.00108	CcSEcCtD
Famotidine—Erythema multiforme—Epirubicin—testicular cancer	0.000387	0.00108	CcSEcCtD
Famotidine—Alopecia—Methotrexate—testicular cancer	0.000386	0.00108	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—testicular cancer	0.000385	0.00108	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—testicular cancer	0.000383	0.00107	CcSEcCtD
Famotidine—Hypersensitivity—Etoposide—testicular cancer	0.000382	0.00107	CcSEcCtD
Famotidine—Tinnitus—Epirubicin—testicular cancer	0.000381	0.00106	CcSEcCtD
Famotidine—Flushing—Epirubicin—testicular cancer	0.00038	0.00106	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—testicular cancer	0.000378	0.00106	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—testicular cancer	0.000376	0.00105	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—testicular cancer	0.000373	0.00104	CcSEcCtD
Famotidine—Asthenia—Etoposide—testicular cancer	0.000372	0.00104	CcSEcCtD
Famotidine—Back pain—Methotrexate—testicular cancer	0.000368	0.00103	CcSEcCtD
Famotidine—Pruritus—Etoposide—testicular cancer	0.000367	0.00102	CcSEcCtD
Famotidine—Arrhythmia—Epirubicin—testicular cancer	0.000365	0.00102	CcSEcCtD
Famotidine—Alopecia—Epirubicin—testicular cancer	0.000361	0.00101	CcSEcCtD
Famotidine—Vomiting—Cisplatin—testicular cancer	0.00036	0.001	CcSEcCtD
Famotidine—Mental disorder—Epirubicin—testicular cancer	0.000358	0.001	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—testicular cancer	0.000358	0.000999	CcSEcCtD
Famotidine—Rash—Cisplatin—testicular cancer	0.000357	0.000996	CcSEcCtD
Famotidine—Dermatitis—Cisplatin—testicular cancer	0.000356	0.000995	CcSEcCtD
Famotidine—Diarrhoea—Etoposide—testicular cancer	0.000355	0.00099	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—testicular cancer	0.000353	0.000985	CcSEcCtD
Famotidine—Anaemia—Methotrexate—testicular cancer	0.000352	0.000982	CcSEcCtD
Famotidine—Flushing—Doxorubicin—testicular cancer	0.000351	0.00098	CcSEcCtD
Famotidine—Dysgeusia—Epirubicin—testicular cancer	0.000349	0.000973	CcSEcCtD
Famotidine—Back pain—Epirubicin—testicular cancer	0.000344	0.000961	CcSEcCtD
Famotidine—Dizziness—Etoposide—testicular cancer	0.000343	0.000957	CcSEcCtD
Famotidine—Muscle spasms—Epirubicin—testicular cancer	0.000342	0.000955	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—testicular cancer	0.000341	0.000951	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—testicular cancer	0.000338	0.000944	CcSEcCtD
Famotidine—Nausea—Cisplatin—testicular cancer	0.000336	0.000938	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—testicular cancer	0.000334	0.000933	CcSEcCtD
Famotidine—Cough—Methotrexate—testicular cancer	0.000332	0.000927	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—testicular cancer	0.000332	0.000925	CcSEcCtD
Famotidine—Convulsion—Methotrexate—testicular cancer	0.00033	0.00092	CcSEcCtD
Famotidine—Vomiting—Etoposide—testicular cancer	0.00033	0.00092	CcSEcCtD
Famotidine—Anaemia—Epirubicin—testicular cancer	0.000329	0.000919	CcSEcCtD
Famotidine—Agitation—Epirubicin—testicular cancer	0.000327	0.000913	CcSEcCtD
Famotidine—Rash—Etoposide—testicular cancer	0.000327	0.000912	CcSEcCtD
Famotidine—Dermatitis—Etoposide—testicular cancer	0.000327	0.000911	CcSEcCtD
Famotidine—Headache—Etoposide—testicular cancer	0.000325	0.000906	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—testicular cancer	0.000324	0.000904	CcSEcCtD
Famotidine—Myalgia—Methotrexate—testicular cancer	0.000324	0.000904	CcSEcCtD
Famotidine—Chest pain—Methotrexate—testicular cancer	0.000324	0.000904	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—testicular cancer	0.000323	0.0009	CcSEcCtD
Famotidine—Syncope—Epirubicin—testicular cancer	0.000319	0.000891	CcSEcCtD
Famotidine—Leukopenia—Epirubicin—testicular cancer	0.000319	0.00089	CcSEcCtD
Famotidine—Back pain—Doxorubicin—testicular cancer	0.000319	0.000889	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—testicular cancer	0.000317	0.000884	CcSEcCtD
Famotidine—Palpitations—Epirubicin—testicular cancer	0.000315	0.000878	CcSEcCtD
Famotidine—Confusional state—Methotrexate—testicular cancer	0.000313	0.000874	CcSEcCtD
Famotidine—Loss of consciousness—Epirubicin—testicular cancer	0.000313	0.000873	CcSEcCtD
Famotidine—Cough—Epirubicin—testicular cancer	0.000311	0.000867	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—testicular cancer	0.000311	0.000867	CcSEcCtD
Famotidine—Convulsion—Epirubicin—testicular cancer	0.000309	0.000861	CcSEcCtD
Famotidine—Infection—Methotrexate—testicular cancer	0.000308	0.000861	CcSEcCtD
Famotidine—Nausea—Etoposide—testicular cancer	0.000308	0.000859	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—testicular cancer	0.000305	0.00085	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000304	0.000849	CcSEcCtD
Famotidine—Chest pain—Epirubicin—testicular cancer	0.000303	0.000846	CcSEcCtD
Famotidine—Arthralgia—Epirubicin—testicular cancer	0.000303	0.000846	CcSEcCtD
Famotidine—Myalgia—Epirubicin—testicular cancer	0.000303	0.000846	CcSEcCtD
Famotidine—Agitation—Doxorubicin—testicular cancer	0.000303	0.000845	CcSEcCtD
Famotidine—Anxiety—Epirubicin—testicular cancer	0.000302	0.000843	CcSEcCtD
Famotidine—Dry mouth—Epirubicin—testicular cancer	0.000296	0.000827	CcSEcCtD
Famotidine—Anorexia—Methotrexate—testicular cancer	0.000296	0.000826	CcSEcCtD
Famotidine—Syncope—Doxorubicin—testicular cancer	0.000295	0.000825	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—testicular cancer	0.000295	0.000823	CcSEcCtD
Famotidine—Confusional state—Epirubicin—testicular cancer	0.000293	0.000818	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—testicular cancer	0.000291	0.000813	CcSEcCtD
Famotidine—Anaphylactic shock—Epirubicin—testicular cancer	0.000291	0.000811	CcSEcCtD
Famotidine—Oedema—Epirubicin—testicular cancer	0.000291	0.000811	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—testicular cancer	0.00029	0.000808	CcSEcCtD
Famotidine—Infection—Epirubicin—testicular cancer	0.000289	0.000806	CcSEcCtD
Famotidine—Cough—Doxorubicin—testicular cancer	0.000287	0.000802	CcSEcCtD
Famotidine—Shock—Epirubicin—testicular cancer	0.000286	0.000798	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—testicular cancer	0.000285	0.000797	CcSEcCtD
Famotidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000285	0.000794	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000283	0.00079	CcSEcCtD
Famotidine—Insomnia—Methotrexate—testicular cancer	0.000281	0.000784	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—testicular cancer	0.00028	0.000783	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—testicular cancer	0.00028	0.000783	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—testicular cancer	0.00028	0.000783	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—testicular cancer	0.00028	0.00078	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—testicular cancer	0.000279	0.000778	CcSEcCtD
Famotidine—Anorexia—Epirubicin—testicular cancer	0.000277	0.000773	CcSEcCtD
Famotidine—Somnolence—Methotrexate—testicular cancer	0.000276	0.00077	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—testicular cancer	0.000274	0.000766	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—testicular cancer	0.000273	0.000763	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—testicular cancer	0.000271	0.000757	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—testicular cancer	0.00027	0.000753	CcSEcCtD
Famotidine—Oedema—Doxorubicin—testicular cancer	0.000269	0.00075	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000269	0.00075	CcSEcCtD
Famotidine—Fatigue—Methotrexate—testicular cancer	0.000268	0.000747	CcSEcCtD
Famotidine—Infection—Doxorubicin—testicular cancer	0.000267	0.000746	CcSEcCtD
Famotidine—Pain—Methotrexate—testicular cancer	0.000266	0.000741	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000265	0.000739	CcSEcCtD
Famotidine—Shock—Doxorubicin—testicular cancer	0.000265	0.000738	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000263	0.000735	CcSEcCtD
Famotidine—Insomnia—Epirubicin—testicular cancer	0.000263	0.000734	CcSEcCtD
Famotidine—Paraesthesia—Epirubicin—testicular cancer	0.000261	0.000728	CcSEcCtD
Famotidine—Somnolence—Epirubicin—testicular cancer	0.000258	0.000721	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—testicular cancer	0.000256	0.000715	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—testicular cancer	0.000256	0.000714	CcSEcCtD
Famotidine—Dyspepsia—Epirubicin—testicular cancer	0.000256	0.000714	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000254	0.000709	CcSEcCtD
Famotidine—Decreased appetite—Epirubicin—testicular cancer	0.000253	0.000705	CcSEcCtD
Famotidine—Fatigue—Epirubicin—testicular cancer	0.000251	0.000699	CcSEcCtD
Famotidine—Pain—Epirubicin—testicular cancer	0.000249	0.000694	CcSEcCtD
Famotidine—Constipation—Epirubicin—testicular cancer	0.000249	0.000694	CcSEcCtD
Famotidine—Urticaria—Methotrexate—testicular cancer	0.000247	0.000689	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—testicular cancer	0.000245	0.000685	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—testicular cancer	0.000245	0.000685	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000245	0.000684	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—testicular cancer	0.000243	0.000679	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—testicular cancer	0.000241	0.000674	CcSEcCtD
Famotidine—Feeling abnormal—Epirubicin—testicular cancer	0.000239	0.000668	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—testicular cancer	0.000239	0.000667	CcSEcCtD
Famotidine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000238	0.000663	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—testicular cancer	0.000237	0.000661	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—testicular cancer	0.000234	0.000652	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—testicular cancer	0.000232	0.000647	CcSEcCtD
Famotidine—Urticaria—Epirubicin—testicular cancer	0.000231	0.000644	CcSEcCtD
Famotidine—Pain—Doxorubicin—testicular cancer	0.00023	0.000642	CcSEcCtD
Famotidine—Constipation—Doxorubicin—testicular cancer	0.00023	0.000642	CcSEcCtD
Famotidine—Body temperature increased—Epirubicin—testicular cancer	0.00023	0.000641	CcSEcCtD
Famotidine—Abdominal pain—Epirubicin—testicular cancer	0.00023	0.000641	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—testicular cancer	0.000229	0.000639	CcSEcCtD
Famotidine—Asthenia—Methotrexate—testicular cancer	0.000223	0.000622	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000222	0.000618	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00022	0.000614	CcSEcCtD
Famotidine—Pruritus—Methotrexate—testicular cancer	0.00022	0.000613	CcSEcCtD
Famotidine—Hypersensitivity—Epirubicin—testicular cancer	0.000214	0.000598	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—testicular cancer	0.000214	0.000596	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—testicular cancer	0.000213	0.000593	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—testicular cancer	0.000213	0.000593	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—testicular cancer	0.000212	0.000593	CcSEcCtD
Famotidine—Asthenia—Epirubicin—testicular cancer	0.000208	0.000582	CcSEcCtD
Famotidine—Pruritus—Epirubicin—testicular cancer	0.000206	0.000574	CcSEcCtD
Famotidine—Dizziness—Methotrexate—testicular cancer	0.000205	0.000573	CcSEcCtD
Famotidine—Diarrhoea—Epirubicin—testicular cancer	0.000199	0.000555	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—testicular cancer	0.000198	0.000553	CcSEcCtD
Famotidine—Vomiting—Methotrexate—testicular cancer	0.000197	0.000551	CcSEcCtD
Famotidine—Rash—Methotrexate—testicular cancer	0.000196	0.000546	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—testicular cancer	0.000196	0.000546	CcSEcCtD
Famotidine—Headache—Methotrexate—testicular cancer	0.000195	0.000543	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—testicular cancer	0.000193	0.000538	CcSEcCtD
Famotidine—Dizziness—Epirubicin—testicular cancer	0.000192	0.000536	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—testicular cancer	0.00019	0.000531	CcSEcCtD
Famotidine—Vomiting—Epirubicin—testicular cancer	0.000185	0.000516	CcSEcCtD
Famotidine—Nausea—Methotrexate—testicular cancer	0.000184	0.000515	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—testicular cancer	0.000184	0.000513	CcSEcCtD
Famotidine—Rash—Epirubicin—testicular cancer	0.000183	0.000511	CcSEcCtD
Famotidine—Dermatitis—Epirubicin—testicular cancer	0.000183	0.000511	CcSEcCtD
Famotidine—Headache—Epirubicin—testicular cancer	0.000182	0.000508	CcSEcCtD
Famotidine—Dizziness—Doxorubicin—testicular cancer	0.000178	0.000496	CcSEcCtD
Famotidine—Nausea—Epirubicin—testicular cancer	0.000173	0.000482	CcSEcCtD
Famotidine—Vomiting—Doxorubicin—testicular cancer	0.000171	0.000477	CcSEcCtD
Famotidine—Rash—Doxorubicin—testicular cancer	0.00017	0.000473	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—testicular cancer	0.000169	0.000473	CcSEcCtD
Famotidine—Headache—Doxorubicin—testicular cancer	0.000168	0.00047	CcSEcCtD
Famotidine—Nausea—Doxorubicin—testicular cancer	0.00016	0.000446	CcSEcCtD
